Canadian researchers on promising path towards developing flu treatment using lipid target
A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection
Widespread off-label use of epilepsy medications could put some patients at risk
Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain
Harnessing the body’s power in fight against cancer
Immunotherapy has provided lung cancer patients with real hope of recovery
Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell
The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.
Children in Quebec are not diagnosed early enough with type 1 diabetes
A study reveals a rise in the number of children presenting a life-threatening complication at diagnosis.
The unanticipated early origins of childhood brain cancer
Canadian researchers identify earliest traces of brain cancer long before the disease becomes symptomatic
Maternal gestational diabetes linked to diabetes in children
Children of mothers who had gestational diabetes during pregnancy could be at increased risk of type 1 diabetes themselves
Increase in children and teens seen in ERs for suicide attempts and suicidal thoughts
Lead study author and RI-MUHC researcher Brett Burstein reports an alarming rise in suicidal behaviour over the last decade
Predicting Breast Cancer Metastasis to the Lung and Liver with Biomarkers
RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung
Anti-TB drugs can increase risk of TB re-infection
Treatment leads to changes in gut microbiota, compromising immunity